Drugs / PD-1 mRNA LNP Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07053072 | Oct 2025 → Sep 2026 overdue | liver cancer | West China Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PD-1 mRNA LNP Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07053072 ↗ |
| Modality | Messenger RNA (mRNA) | “PD-1 mRNA LNP is an immune checkpoint mRNA vaccine” NCT07053072 ↗ |